INGN 9.43 Stock Price Inogen, Inc.
Range: | 4.93-13.33 | Vol Avg: | 188160 | Last Div: | 0 | Changes: | 0.17 |
Beta: | 1.05 | Cap: | 0.22B | Currency: | USD | Exchange: | NASDAQ |
Sector: | Healthcare | IPO: | Fri Feb 14 2014 | Empoloyees: | 834 |
CUSIP: | 45780L104 | CIK: | 0001294133 | ISIN: | US45780L1044 | Country: | US |
CEO: | Mr. Kevin R. M. Smith | Website: | https://www.inogen.com |
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.